Back to search

Poland· PL-100167240

Gencjana 0,5% roztwór wodny

A other antiseptics and disinfectants product containing methylrosanilinii chloridum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 7 of our 19 countries.

ATC D08AX

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedGencjana 0,5% roztwór wodnyATCD08AXREGISTER NO.PL-100167240PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Methylrosanilinii chloridum is registered in 7 of 19 countries.

Countries holding a registration under ATC D08AX (other antiseptics and disinfectants), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Methylrosanilinii chloridum · ATC D08AX

7 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Methylrosanilinii chloridum
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
D08AX
ATC class
Other antiseptics and disinfectants
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990668212
  • gtin
    05909990668229

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Methylrosanilinii chloridum in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylrosanilinii chloridum products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b72be1e9-5d79-4ee2-8f69-ece9acd8e91c
GET /v1/drugs/b72be1e9-5d79-4ee2-8f69-ece9acd8e91c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór na skórę",
  "source": "urpl",
  "strength": "5 mg/g",
  "packaging": "05909990668212 ¦ OTC ¦ 7984\n1 butelka 20 g\n05909990668229 ¦ OTC ¦ 7985\n1 butelka 100 g",
  "substance": "Methylrosanilinii chloridum 0.5 g",
  "common_name": "Methylrosanilinii chloridum",
  "pl_product_id": "100167240",
  "pozwolenie_nr": "06682",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about methylrosanilinii chloridum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.